USA - engelsk - NLM (National Library of Medicine)

amneal pharmaceuticals ny llc - trientine hydrochloride (unii: hc3nx54582) (trientine - unii:sj76y07h5f) - trientine hcl capsules are indicated in the treatment of patients with wilson’s disease who are intolerant of penicillamine. clinical experience with trientine hcl capsules is limited and alternate dosing regimens have not been well-characterized; all endpoints in determining an individual patient’s dose have not been well defined. trientine hcl capsules and penicillamine cannot be considered interchangeable. trientine hcl capsules should be used when continued treatment with penicillamine is no longer possible because of intolerable or life endangering side effects. unlike penicillamine, trientine hcl capsules are not recommended in cystinuria or rheumatoid arthritis. the absence of a sulfhydryl moiety renders it incapable of binding cystine and, therefore, it is of no use in cystinuria. in 15 patients with rheumatoid arthritis, trientine hcl capsules was reported not to be effective in improving any clinical or biochemical parameter after 12 weeks of treatment. trientine hcl capsules are not indicated for t

USA - engelsk - NLM (National Library of Medicine)

camber pharmaceuticals, inc. - trientine hydrochloride (unii: hc3nx54582) (trientine - unii:sj76y07h5f) - trientine hydrochloride capsules are indicated in the treatment of patients with wilson’s disease who are intolerant of penicillamine. clinical experience with trientine hydrochloride capsules are limited and alternate dosing regimens have not been well-characterized; all endpoints in determining an individual patient’s dose have not been well defined. trientine hydrochloride capsules and penicillamine cannot be considered interchangeable. trientine hydrochloride capsules should be used when continued treatment with penicillamine is no longer possible because of intolerable or life endangering side effects. unlike penicillamine, trientine hydrochloride capsules are not recommended in cystinuria or rheumatoid arthritis. the absence of a sulfhydryl moiety renders it incapable of binding cystine and, therefore, it is of no use in cystinuria. in 15 patients with rheumatoid arthritis, trientine hydrochloride was reported not to be effective in improving any clinical or biochemical parameter after 12

Storbritannien - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - trientine dihydrochloride - oral capsule - 200mg

Storbritannien - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

univar solutions b.v. - trientine dihydrochloride - oral capsule - 200mg

Saudi-Arabien - engelsk - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

navinta llc, united states - trientine dihydrochloride - capsule, hard - 250 mg,

Storbritannien - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

tillomed laboratories ltd - trientine dihydrochloride - oral capsule - 250mg

Saudi-Arabien - engelsk - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

tillomed laboratories limited, united kingdom - trientine dihydrochloride - capsule, hard - 250 mg,

USA - engelsk - NLM (National Library of Medicine)

lannett company inc. - trientine hydrochloride (unii: hc3nx54582) (trientine - unii:sj76y07h5f) - trientine hydrochloride capsule is indicated in the treatment of patients with wilson's disease who are intolerant of penicillamine. clinical experience with trientine hydrochloride capsule is limited and alternate dosing regimens have not been well-characterized; all endpoints in determining an individual patient's dose have not been well defined. trientine hydrochloride capsule and penicillamine cannot be considered interchangeable. trientine hydrochloride capsule should be used when continued treatment with penicillamine is no longer possible because of intolerable or life endangering side effects. unlike penicillamine, trientine hydrochloride capsule is not recommended in cystinuria or rheumatoid arthritis. the absence of a sulfhydryl moiety renders it incapable of binding cystine and, therefore, it is of no use in cystinuria. in 15 patients with rheumatoid arthritis, trientine hydrochloride capsule was reported not to be effective in improving any clinical or biochemical parameter after 12 weeks of treat

USA - engelsk - NLM (National Library of Medicine)

navinta llc - trientine hydrochloride (unii: hc3nx54582) (trientine - unii:sj76y07h5f) - trientine hydrochloride capsule is indicated in the treatment of patients with wilson's disease who are intolerant of penicillamine. clinical experience with trientine hydrochloride capsule is limited and alternate dosing regimens have not been well-characterized; all endpoints in determining an individual patient's dose have not been well defined. trientine hydrochloride capsule and penicillamine cannot be considered interchangeable. trientine hydrochloride capsule should be used when continued treatment with penicillamine is no longer possible because of intolerable or life endangering side effects. unlike penicillamine, trientine hydrochloride capsule is not recommended in cystinuria or rheumatoid arthritis. the absence of a sulfhydryl moiety renders it incapable of binding cystine and, therefore, it is of no use in cystinuria. in 15 patients with rheumatoid arthritis, trientine hydrochloride capsule was reported not to be effective in improving any clinical or biochemical parameter after 12 weeks of treat

USA - engelsk - NLM (National Library of Medicine)

zydus pharmaceuticals usa inc. - trientine hydrochloride (unii: hc3nx54582) (trientine - unii:sj76y07h5f) - trientine hydrochloride capsules are indicated in the treatment of patients with wilson's disease who are intolerant of penicillamine. clinical experience with trientine hydrochloride capsules is limited and alternate dosing regimens have not been well-characterized; all endpoints in determining an individual patient's dose have not been well defmed. trientine hydrochloride capsules and penicillamine cannot be considered interchangeable. trientine hydrochloride capsules should be used when continued treatment with penicillamine is no longer possible because of intolerable or life endangering side effects. unlike penicillamine, trientine hydrochloride capsules are not recommended in cystinuria or rheumatoid arthritis. the absence of a sulfhydryl moiety renders it incapable of binding cystine and, therefore, it is of no use in cystinuria. in 15 patients with rheumatoid arthritis, trientine hydrochloride capsules was reported not to be effective in improving any clinical or biochemical parameter after 12 weeks o